Seaport Therapeutics

Developing new neuropsychiatric medicines, specifically antidepressants and anxiolytics.

HQ location

Boston, United States

Website

Launch date

2024

Employees

Enterprise value

$900m—1.4b

https://x.com/seaporttx https://www.linkedin.com/company/seaport-therapeutics/

Authorizing premium user...